Global workshop on mHealth for Ageing
Date
19 - 21 April 2017
Time
09:00 to 17:30
Location
Campus Biotech, 9 Chemin des Mines, Bldg. H8.01, Room 144.165
Attendance
This event has now passed. To browse our upcoming events click here.
In association with the University of Geneva, IFPMA co-hosted a workshop on mAgeing at the Campus Biotech from 19-21 April, under the Be Healthy Be Mobile initiative, of which IFPMA is a founding partner. A number of experts from WHO’s Department of Ageing and the Life Course, as well as the Be Healthy Be Mobile Secretariat (both WHO and ITU) attended, alongside country experts from India, Zimbabwe and China, academics and industry (J&J, Pfizer and Domosafety). Two “older people” – retirees from the WHO – were also invited to provide testimonials on the challenges of achieving healthy ageing, to provide an “end-user perspective”. The first day of the workshop presented the Be Healthy Be Mobile initiative and the work taking place in countries, academia and the WHO. Breakout sessions were then held, where group discussions explored the main concerns of ageing individuals when implementing an mAgeing program, using a persona activity. The second day contained a panel discussion from the private sector participants. Dr Vaibhav Narayan from J&J discussed the concept of a “brain health score” and the factors behind measuring cognitive declines, Julie Chan from Pfizer presented on the various ways in which Pfizer has engaged in the ageing dialogue, and Philipp Buluschek from Domosafety presented on the technological innovations which allow older people to enable independent home living and reduce dependence on long-term care. The day was also dedicated to group activities for vetting content and mapping it onto a framework to be implemented as an mHealth intervention for ageing, that could fit into a health system. The last day was a half-day session which focused on the challenges of designing monitoring and evaluation (M&E) indicators for an mAgeing program, with one of the main conclusions being that it is extremely difficult to link text messaging and other mHealth interventions through to broader health outcomes and impacts, particularly in the context of ageing compared with other more narrow areas (such as tobacco cessation).
Program
The first day will present BHBM and the work taking place in countries, academia, and a t WHO. We will then go through a persona activity to explore the main c oncerns of aging individuals when implementing an mAging program.
Registration
Welcome address
Workshop overview and objectives
Introductions
WHO conceptual framework on Healthy Aging
Introduction to the Be H e@lthy, Be Mobile initiative
Overview of the Integrated Care for Older
People (ICOPE) guidelines
Questions and open discussion
Coffee break
Country perspectives
•India
•Zimbabwe
•China
Lunch
Panel: Insights into the field o f research on aging
Testimonial from end-users
Coffee break
Group Activity: Personas (4-5 groups)
Groups will explore the profiles of target populations
to understand opportunities f or mHealth
interventions and to inform content validation
Group sharing and open discussion
Awareness of, and strategies to combat ageism
Recap and overview of next day’s activities
Open reception for all participants, hosted by IFPMA
This day will be dedicated to group activities for vetting content and mapping it onto a framework
to be implemented as an mH ealth intervention for aging that could fit into a health s ystem.
Be He@lthy, Be Mobile initiative: Countries
and toolkits
mAging content framework: A comprehensive
approach to aging
Best practices in text message development and
communication strategies for older adults
Group Activity: Content library review
Check-in: Questions and open discussion
Lunch break
Continue content library review
Coffee break
Group sharing and open discussion on important
issues that arose during review
Panel: Innovations in Digital Health and Aging
• “Brain Health Score: Use of everyday data from
smartphones and wearables to develop a single
number that tracks brain health and r esilience”
• “Use cases and ongoing r esearch projects using
mH ealth for ageing”
• “mHealth and healthy ageing approaches
a t Pfizer”
• Questions and open discussion
Recap and overview of next day’s activities
The morning of the last day will be dedicated to discussing M&E indica tors for an mAging program.
Welcome and outline o f the day’s schedule
and objectives
mHealth M&E framework and examples in
BHBM countries
Introduction to group activity
Group Activity: Using mHealth M&E logic model,
discuss indicators and measurability
Plenary style: group sharing and open discussion
mAging: next steps towards implementation
Speakers
He is amongst the GDG e xperts
of the WHO ICOPE and mhGAP flagship programs on aging and mental health in low-and middleincome countries (LMICs).
Dr Araujo de Carvalho holds an MD with post-graduate training in obstetrics and gynaecology, a Master’s degree in Public H ealth, and Diplomas in International Health and Gerontology. Islene has worked, for more than 15 years with the UN System (at national, regional and global levels) on community health, health promotion and primary health care. She worked in Latin
American, Africa and Asia in a variety of capacities. In Brazil, she coordinated a State Reproductive Health Programme, before becoming the National Coordinator of the
Brazilian Maternal Health Programme.
In Tanzania and Zimbabwe she was the National Health Coordinator in charge of setting up health service delivery systems
for primary health care, with an emphasis on the prevention and control of non-communicable diseases. She joined the Department of Aging and Life Course in 2013 and leads on WHO’s efforts to align health systems to the needs of older people
with a focus on older person centered and integrated care. She oversees the development and implementation of relevant policy, clinical standards, interventions
and tools. She also supports the translation of research and capacity development in policy and practice with a focus on facilitating its utilization by health professionals in clinical settings.
John initially worked as a physician in South Africa, the United Kingdom and rural Australia, including several years as medical officer for a community controlled Aboriginal Medical Service. He subsequently held a r ange of senior public health and academic
roles in Australia and the USA, including as the founding head of the University of Sydney’s Department of Rural Health,
Manager of Public Health for the Sydney 2000 Olympic Games, and Senior Epidemiologist with the New York Academy of Medicine. He works closely with the World Economic Forum and is a past chair of their Global Agenda Council on Aging and a current member of the Global Council on the Future of Human Enhancement. John remains
actively involved in several large international research studies on aging and he has published widely in the international
literature. He has been an edit or for a number of key publications including the World Economic Forum monograph “Global
Population Aging: Peril or Promise?”, the 2014 Lanc et series on Aging, and the 2013 special issue of the Bulletin of the World
Health Organization on “Women Beyond Reproduction”. He retains his links to the University of Sydney, where he is an
Honorary Professor.
Julie T. Chan is Global Consumer Engagement Lead, Pfizer ConsumerHealthcare. Ms Chan isresponsible
for developing advertising strategies for Pfizer’s global consumer brands, including Advil, Centrum, Caltrate, ChapStick
and Nexium24HR. In leading Pfizer Consumer Healthcare’s global media strategies, Ms. Chan has driven a unique approach
toleveraging consumer insights married with technological innovation. Ms. Chan oversees
strategic development of digital strategies including use of emerging technologies.
Prior to joining Pfizer Consumer Healthcare, during a 13 year career at Johnson & Johnson, she led a team of media professionals responsible for integrated
communications, agency oversight and digital marketing for the company’s consumer, pharmaceutical and medical
device businesses. She is a board member of the World Federation of Advertisers as well as the Mobile Marketing Association. She has also been recognized with the Pfizer Consumer Healthcare President’s Eye-on-Innovation Award.
Dr Joconiah Chirenda is a Public Health Specialist with more than 20 years’ work experience in Communicable Diseases,
Health Systems Strengthening and Mentoring at national, regional and international levels. His programme management and leadership skills were
demonstrated during the times he worked as a Director of National Malaria and Tuberculosis programmes in Zimbabwe and
Botswana respectively. Regional and international-level experience has been through multiple consultancies with the United Nations agencies, European
Union and the World Bank. Currently he is a L ecturer at the College of Health Sciences,
University of Zimbabwe.
Dr. A.B. Dey is the Professor and Head of Geriatric Medicine at All India Institute
of Medical Sciences, New Delhi. A physician by training, he pursued a Fellowship in Geriatrics in Newcastle upon Tyne under
Commonwealth Medical Fellowship in 1995-1996. Since 1997, he has been involved in establishing Geriatrics in India through
research, training and service development. Dr Dey set up the largest post-graduate
Department of Geriatric Medicine in India in 2012. He has been assisting WHO SEARO,
EMRO and WPRO in developing strategies for healthy and active aging; and strengthening old age care in health systems in countries of these regions.
Dr Forbes began her academic career at the University of Saskatchewan, then Western
University and currently with the University of Alberta. Her community nursing experiences
drive her program of research that focuses on improving the quality of life for persons with dementia, their family caregivers,
and formal care providers through integrated knowledge translation strategies that enhance quality and safe dementia care in the home. She continues to conduct
Cochrane Reviews on the effectiveness of exercise in managing the symptoms of
dementia. Dr Forbes is a coapplicant
on several research studies and was a Visiting
Professor with the Federal University of Rio do Sul in Porto Alegre, Brazil.
Antoine Geissbuhler is a Professor of Medical Informatics at Geneva University School of Medicine and Director of the Division of the Medical Informatics at Geneva University
Hospitals. Dr Geissbuhler graduated from the Geneva University School of Medicine in
1991 as a Philips E uropean Young Scientist first award laureate. He received his doctorate for work on tri-dimensional reconstruction of positron emission tomography images. After completing a post‑doctoral fellowship in medical informatics at Vanderbilt University, he rose to Associate Professor of Biomedical
Informatics and Vice-Chairman of the Division of Biomedical Informatics at Vanderbilt University Medical Center.
There, Dr Geissbuhler worked
primarily on the development of clinical information systems and knowledge-management tools. During his time at Vanderbilt, he was the primary developer of the WizOrder computerized Physician
Order Entry system, which uses integrated decision support and is now being marketed
commercially. In 1999, Dr Geissbuhler returned to Geneva to head the Division of Medical Informatics in Geneva University
Hospitals and School of Medicine. Dr Geissbuhler’s current research focuses on the development of innovative computer-based
tools for improving the quality and efficiency of care processes, at the local level of the hospital, at the regional level of a community
healthcare informatics network, and at the global level with the development of a telemedicine network in Western Africa. He has now been named an international
associate of the American College of Medical Informatics
Allison Goldstein is a Technical Officer for the WHO mHealth secretariat for the joint
UN Initiative Be He@lthy Be Mobile, where she coordinates the technical documents
for countries implementing mHealth programs. From 2012- 2015, she worked for the CDC in the Division for Heart Disease and
Stroke Prevention on the Million Hearts Initiative Science Team. From 2010-2012 she was part of a small team at CARE International funded by the CORE Group
to conduct polio eradication activities. She holds a bachelor’ s degree in Zoological Anthropology from the University of Michigan and a master’s degree in Public
Health from Emory University’s Rollins School of Public Health.
Mikel Izquierdo is Head and full Professor of Biomechanics and Exercise Physiology in the
Department of Health Sciences of the Public University of Navarra. He also holds and an
appointment as a professor of Sport Biomechanics at the Centre of Studies of the Spanish Olympic Committee. Additionally, he
was the Head of the Unit of the Research, Studies and Sport Medicine Center of
the Government of Navarra from 2005-2010 and principal investigator and collaborator
in several EU- funded projects focused on frailty and exercise: VIVIFRAIL to promote and recommend changes in lifestyle
associated with physical exercise for frail patients at risk of functional decline and MIDFRAIL, to test the efficacy of a multimodal intervention in prefrail/frail older patients with type 2 diabetes. His current
research interests include the neuromuscular biomechanics of muscle strength and power
with special interest in strength training in both the elite athlete and the aging human. Pr of. Mikel Izquierdo has published more
than 200 original articles in peer-reviewed journals. researchgate.net/profile/Mikel_
Izquierdo/publications/
Surabhi Joshi is Technical Officer in the Be He@lthy, Be Mobile initiative of the WHO and ITU. She supports country implementation and monitoring and evaluation of mHealth programs for NCDs. She holds an MPP from the School of
Public Health at Johns Hopkins University, where she was a Fulbright-Nehru Scholar. She has previously worked in the
Department of Health Statistics and Information Systems at WHO Geneva, International Union for TB and Lung Diseases (IUTLD) in New Delhi, UNAIDS Technical
Support Facility at Nepal, and the National AIDS Control Organization, Ministry of
Health in New Delhi.
Jill is a member of the faculty at L V Prasad Eye Institute in Hyderabad, India and has an
honorary appointment at the Department of Ophthalmology at the University of Melbourne. She holds the position o f Chair
of the International Agency for Prevention of Blindness Low Vision Working Group.
She worked with the World Health Organization (WHO) for many years as Director of the WHO Collaborating Centre for
Prevention of Blindness at the Centre for Eye Research Australia. Professor Keeffe received an Order of Australia Medal in 2007
for services to eye care education and practice.
Qurat ul Ain Khan, M.D. completed his MBBS from Dow Medical College in Karachi, Pakistan, completed his residency in General Psychiatry from Chicago Medical School in
the U.S. in 2011 and a f ellowship in Behavioral Neurology and Neuropsychiatry from the Mayo Clinic in Jacksonville, FL. He is
certified by the American Board
of Psychiatry and Neurology (General Psychiatry) and United Council for Neurologic
Subspecialties (Behavioral Neurology and Neuropsychiatry) and joined Aga Khan University Hospital as Assistant Professor
in 2013, working as a clinician, academician and researcher.
Matthias Kliegel is full professor of psychology and the chair of cognitive aging at the School of Psychology at the University of Geneva. He is also the dir ector of the Geneva Aging Center (Centre interfacultaire de gérontologie et d’études des vulnérabilités CIGEV), co-leading house of
the Swiss National Centre of Competence in Research LIVES – Overcoming vulnerability:
Life course perspectives. His research, funded, for example, by the Swiss National Science Foundation, the German Research Council or the Australian Research Council,
focuses on cognitive health across the lifespan where he has published more than 200 peer-reviewed papers (for more information see: unige.ch/ fapse/aging/fr/members/kliegel/)
Professor Chiung-Ju Liu is Associate Professor at the School of Health and Rehabilitation Sciences, Department of
Occupational Therapy. Her research goal is to identify modifiable factors and to develop
effective interventions that will enable older adults to live an independent and healthy life. She has two research foci: preventing
late-life disability prevention and promoting health literacy. Her research efforts in late-life
disability prevention include: 1) identifying the benefit and limitation of muscle strength
training on reducing physical functioning in older adults; and 2) developing and testing a
therapeutic home-based exercise program to overcome the limitation of muscle strength
training. Her research efforts in health literacy promotion include examining the effect of 1)
increasing text cohesion and 2) using illustrations or multimedia on processing and comprehension of health information for
older adults.
Vaibhav is currently Vice President of Research IT at Janssen Pharmaceuticals LLC,
where he is responsible for programs that utilize data, analytics and digital health
technologies to transform research innovation capabilities across Janssen R&D. Vaibhav also holds the position o f Head,
Integrated Solutions, Janssen Neuroscience. In this role, Vaibhav is leading e fforts to
develop technology enabled solutions for early detection, disease monitoring and relapse prediction in Alzheimer’s Disease,
Major Depressive Disorders and Schizophrenia. Vaibhav joined Johnson and Johnson from Eli Lilly and Co., where he
headed the Discovery and Biomedical Informatics group responsible for enabling Eli
Lilly’s translational, biomarker,
and tailored therapeutics strategies. Prior to Eli Lilly, Vaibhav held multiple leadership
roles in various small to midsize biotech companies such as Celera Genomics, CuraGen Corporation and Vertex
pharmaceuticals during which time he participated in multiple landmark ‘Big Biology’ projects, including sequencing, assembly and analysis of the human genome (the Human Genome Project). Vaibhav obtained his PhD from Yale University
jointly from the Departments of Chemistry, and Molecular Biophysics & Biochemistry in
1998, and an Ex ecutive MBA from Kellogg School of Management, Northwestern University in 2009.
Hiroko Nishimoto has been Japan Liaison Executive at IFPMA since May 2015. As a member of the global health policy team,
she facilitates coordination between the IFPMA and Japanese Pharmaceutical Manufacturers Association (JPMA) on polic y
decisions and global health partnerships. Hiroko holds a MBA degree from Waseda
Business School and a B A in English Literature from Doshisha University in Japan. Prior to joining IFPMA, she has worked for Astellas Pharma Inc. for 12 years in Japan,
most recently in its corporate planning function, its CSR, and project management of Astellas’ global health initiatives.
Michel Oris is a full professor at the School of Social Sciences, University of Geneva. Vicerector for Research and Human
Resources since mid-July 2015, he was previously the director of the Interdisciplinary Center for Gerontology and Vulnerability
Studies and codirector of the Swiss National Centre of Competency in Research “LIVES.
Overcoming Vulnerabilities. Life Course Perspectives”. His research focuses on inequalities, with an emphasis on the living and health conditions of the elderly,
injustices regarding death, and interactions between individual trajectories and the dynamics of social structures, between
vulnerabilities and life courses.
Vanessa covers policy affairs in relations to global health issues, with specific interest in
aging and non-communicable diseases (NCDs). Vanessa holds a master’s degree in Development Studies from the London School of Economics and Political Science,
and a bachelor’s degree in Economics from University College London. Prior to joining
IFPMA, Vanessa worked at the Economist Intelligence Unit (EIU), where she was responsible for delivering economic, policy and business analysis and advisory services to clients across Europe, Middle East and Africa, working in part with EIU Healthcare, the healthcare arm of EIU. Before that, Vanessa was a Senior Consultant at GHK Consulting,
a public policy consultancy specializing in the evaluation of public projects and programs
in the UK and Europe.
Dr Terje Peetso joined the Unit Health and Wellbeing in DG Communications Networks,
Content and Technology in 2011. Her main responsibilities are related to the coordination of the implementation of the eHealth Action Plan 2012 – 2020 as well
as the overall coordination of the policy group in the Unit. In 2014 she was the EU Fellow in the University of Southern
California, USA, where her research focus was on the obstacles which hinder the introduction eHealth in healthcare systems.
Dr Peetso has been working in the European Commission since 2003 starting as a
Scientific Secretary in the Risk Assessment Unit in DG Health and Consumers. In 2006 she became a policy officer in the area of
tobacco control in the same DG. Dr Peetso holds a diploma in medicine from the University of Tartu, Estonia.
Silvia is the Chair of the NGO Committee on Aging at the UN in Geneva. An advocate for the human rights of older persons, she focuses on the intersection of gender, disability and aging. At WHO (1999-2005), Silvia worked on health promotion, aging and NCDs issues. At UICC (2007-2008) she managed a team on cancer prevention and
capacity building and produced the first international film festival on cancer. Since 2009, as an independent consultant she
has evaluated projects, written reports and concept papers on a variety of health issues, including NCDs and e-health. She has an
MSc in Inter-professional Practice (health sciences) from City University, London.
Dr Bhanu Pratap is a M edical Doctor (N.Delhi), International MPH (Israel), International Diploma in Humanitarian
Assistance(USA) and Postgraduate diploma in Disaster Preparedness & Rehabilitation (India). He possesses more than 15 years’
experience with Ministry of Health, NGOs, Red Cross & Research organizations in many
countries in Middle East, South and South-east Asia in public health, resilience, emergency and conflicts. Currently as Senior
Officer – Care in the community in Health and Care Department of International Federation of Red Cross and Red Crescent Societies (IFRC) Geneva, He leads Healthy
Aging, First Aid and Mental Health Psychosocial support in close coordination with global reference centres and Care and support in communities.
Sameer Pujari is part o f the secretariat for the flagship WHO and ITU joint program on
mHealth for Non-Communicable Diseases; Be He@lthy Be Mobile. Working at WHO since 2008, he has also provided technical
advice and support to over 35 countries in the development of surveillance and management information systems. Prior to
joining WHO, he worked with the US Government’s health agency helping various countries build informatics systems for
immunization and vaccination programs in Asia, Europe and Africa. He started his career
working with WHO’s National Polio Surveillance Project in India for 7 years, where he led the development and implementation of various information management systems for surveillance
across the country.
Dr René Rizzoli is an in ternist and endocrinologist, with a subspecialty focus on metabolic bone diseases, osteoporosis and
disorders of mineral metabolism. He is presently emeritus professor of medicine at the Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland, where he used to be the head of the Division o f Bone
Diseases and the chair of the Department of Geriatrics. Dr. Rizzoli is the former chairman
of the Committee of Scientific Advisors of the International Osteoporosis Foundation, of
which he is now the treasurer. He is the chairman of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and
Osteoarthritis, and co-chairing the scientific program committee of the annual IOF-ESCEO
congress. He is involved in both basic and clinical research projects investigating hormone action, regulation of bone growth,
pathophysiology of osteoporosis and of calcium and phosphate homeostasis disorders, and the role of nutrition, calcium,
protein, bisphosphonates, selective estrogen modulators, parathyroid hormone, denosumab and strontium ranelate in the
prevention and treatment of osteoporosis. Dr. Rizzoli is author of more than 850 scientific articles, editor‑in‑chief of Calcified Tissue International and Musculoskeletal
Research and associate editor of
Osteoporosis International.
Professor Suzanne Suggs is an Associate Professor of Social Marketing and Head
of the BeCHANGE Research Group in the Institute for Public Communication, Faculty
of Communication Sciences, Università della Svizzera italiana (USI), in Lugano, Switzerland. She is Vice-Director of the Consumer
Behavior Lab and Director of the Sustainability Incubator (SINC) at USI. Additionally, she is a Visiting Reader in the Institut e for Global Health Innovation at Imperial College London and is a F ellow in
the Swiss School of Public Health. Her research focuses on health behavior change and health communication, using a social
marketing approach and ITC.
Yuka Sumi MD, PhD is a certified specialist of Japanese Acute and Critical Care Medicine and Japan Surgical Society. She has worked
as an associate professor in the Department of Emergency and Critical Care Medicine and in the Faculty of Gerontology in
Juntendo University. In 2016, she joined the Healthcare New Frontier Promotion Headquarters Office in Kanagawa Prefectural
Government in Japan as a senior project leader of global Health. Since December 2016, she has joined the WHO Department
of Aging and Life Course as a secondment from Kanagawa Prefectural Government and
she is currently developing the clinical guidelines for Integrated Care for Older People (ICOPE) in primary care settings
and working on the mAging program with the BHBM initiative.
Ms. Fang WANG, now works as a researcher on health policy at Institute of Medical Information/Center for Health Policy and Management, Chinese Academy of Medical
Sciences. Dr Wang completed her M.A. from Mahidol University in Thailand in 2002, and her MD from Huazhong University
of Science and Technology, China in 2006. In 2012, granted by CMB, she finished as visiting scholar at the Institute of Health
Policy and Management (iBMG) in Erasmus University, Rotterdam. Dr Wang has worked on primary health care issues for 15 years, and also has an interest in integrated health and pension care for older people.
Diane Wu holds an MD from the University of British Columbia, Canada, and an MPH from Harvard University, USA. Diane is board
certified in Family Medicine in Canada. She has worked in medicine, public health, and
management consulting in China, Laos, Bosnia-Herzegovina, England, Switzerland, Canada, and the United States. She has
held research, technical and operational support roles with the Alliance for Health Policy and Systems Research, the University of Toronto, Global Affairs Canada and for a multinational private sector consulting firm.
She joined the Department of Aging and Life Course in 2016 and currently supports the
management of WHO partnerships, communications and advocacy, and the development of new platforms to support innovation in healthy aging.